Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review

被引:33
|
作者
Hase, Isano [1 ,2 ]
Morimoto, Kozo [3 ]
Sakagami, Takuro [4 ]
Ishii, Yoshiki [2 ]
van Ingen, Jakko [5 ]
机构
[1] Utsunomiya Hosp, Natl Hosp Org, Dept Resp Med, 2160 Shimo Okamoto, Utsunomiya, Tochigi 3291193, Japan
[2] Dokkyo Med Univ, Dept Pulm Med & Clin Immunol, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan
[3] Fukujuji Hosp, Japan AntiTB Assoc, Resp Dis Ctr, 3-1-24 Matsuyama, Kiyose, Tokyo 2040022, Japan
[4] Niigata Univ, Grad Sch Med & Dent Sci, Dept Resp Med & Infect Dis, 1-757 Asahimachi Dori, Niigata, Niigata 9518510, Japan
[5] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, POB 9101, NL-6500 HB Nijmegen, Netherlands
关键词
Anti-interferon-gamma autoantibody; Nontuberculous mycobacterium; Clinical manifestation; Ethnicity; Adult-onset immunodeficiency; ADULT-ONSET IMMUNODEFICIENCY; AVIUM COMPLEX INFECTION; ACQUIRED-IMMUNODEFICIENCY; MENDELIAN SUSCEPTIBILITY; RECURRENT; TOXOPLASMOSIS; RITUXIMAB; DIAGNOSIS;
D O I
10.1016/j.diagmicrobio.2017.05.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Nontuberculous mycobacteria (NTM) infections involving anti-interferon-gamma(IFN-gamma)-neutralizing auto antibodies have been described in previously immunocompetent adults. To investigate the factors underlying various disease manifestations, we reviewed 35 articles published between January 2004 and November 2016 and identified 111 NTM patients with anti-IFN-gamma, autoantibodies. Rapidly growing mycobacteria (RGM) accounted for 53% of the isolated species. RGM were predominant among the NTM species isolated from Thai (73%), Chinese (58%) and Filipino (56%) patients, whereas M. avium complex (MAC) was predominant among Japanese (58%) and non-Asian (80%) patients. The commonly involved organs included the lymph nodes (79%), bones/joints (34%) and lungs (32%). Compared with the patients with MAC, the patients with RGM had a higher incidence of lymph node lesions (P < 0.05) and a lower incidence of bone/joint (P < 0.01), lung (P < 0.01), soft tissue (P < 0.01), bronchus (P < 0.01) and muscle (P < 0.05) lesions. Clinical manifestations of NTM disease with anti-IFN-gamma-neutralizing autoantibodies differ across ethnicities and NTM species. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:308 / 315
页数:8
相关论文
共 38 条
  • [31] The unique diagnostic and management challenge of a patient with concomitant anti-interferon-gamma autoantibody associated immunodeficiency syndrome, IgG4-related disease, and treatment refractory, disseminated mycobacterium avium complex infection
    Spencer Boyle
    Ashley Hagiya
    Minh-Vu H. Nguyen
    Howard Liebman
    Jin Sol G. Lee
    Allergy, Asthma & Clinical Immunology, 18
  • [32] The unique diagnostic and management challenge of a patient with concomitant anti-interferon-gamma autoantibody associated immunodeficiency syndrome, IgG4-related disease, and treatment refractory, disseminated mycobacterium avium complex infection
    Boyle, Spencer
    Hagiya, Ashley
    Nguyen, Minh-Vu H.
    Liebman, Howard
    Lee, Jin Sol G.
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2022, 18 (01):
  • [33] Disseminated Mycolicibacter arupensis and Mycobacterium avium co-infection in a patient with anti-interferon-γ neutralizing autoantibody-associated immunodeficiency syndrome
    Hirayama, Kaho
    Kanda, Naoki
    Suzuki, Takayuki
    Sasaki, Kazumasa
    Kimura, Yumiko
    Takahashi, Kento
    Matsumura, Masami
    Hatakeyama, Shuji
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (09) : 1336 - 1339
  • [34] Non-tuberculous mycobacterial infection and reactive dermatosis associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibodies A case report
    Liang, Xiao-Na
    Bin, Yan-Fei
    Lai, Guan-Ting
    Li, Ying-Hua
    Zhang, Jian-Quan
    Zhong, Xiao-Ning
    Bai, Jing
    Li, Mei-Hua
    Deng, Jing-Min
    He, Zhi-Yi
    MEDICINE, 2020, 99 (36) : E21738
  • [35] USE OF EMAPALUMAB (ANTI-INTERFERON-GAMMA MONOCLONAL ANTIBODY) FOR ACTIVE DISEASE CONTROL FOLLOWED BY HEMATOPOETIC CELL TRANSPLANTATION IN A PATIENT WITH REFRACTORY SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS WITH ASSOCIATED LUNG DISEASE
    Chellapandian, Deepak
    Vaughn, Gretchen
    Milojevic, Diana
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S7 - S8
  • [36] Cervical abscess caused by Mycobacterium tilburgii in a patient carrying anti-interferon gamma autoantibody: A case report and literature review
    Shinohara, Koh
    Matsumura, Yasufumi
    Sakagami, Takuro
    Morioka, Shigefumi
    Yoshizawa, Kazutaka
    Aoki, Kazuaki
    Motobayashi, Hirofumi
    Tochitani, Kentaro
    Nagao, Miki
    Shimizu, Tsunehiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (05) : 699 - 704
  • [37] Detailed tracking of antigen and antibody levels during coronavirus disease 2019 treatment in an immunosuppressed patient with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
    Yukishima, Toshitaka
    Furuhashi, Kazuki
    Shimoyama, Kumiko
    Taki, Takeru
    Azuma, Chika
    Yamazaki, Kenji
    Furukawa, Shogo
    Fukami, Soma
    Nagura, Osanori
    Katahashi, Kazuto
    Yamashita, Keita
    Maekawa, Masato
    Ogawa, Noriyoshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (09) : 922 - 927
  • [38] Blockade of the Terminal Complement Cascade Using Ravulizumab in a Pediatric Patient With Anti-complement Factor H Autoantibody-Associated aHUS: A Case Report and Literature Review
    Wu, Xiaoyan
    Szarzanowicz, Amanda
    Garba, Adinoyi
    Schaefer, Beverly
    Waz, Wayne R.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)